Howard Hughes Medical Institute’s Boston Scientific BSX Stock Holding History

Howard Hughes Medical Institute’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-319	Closed	-$30.4K	–	95
2025 Q4	$30.4K	Buy	319 +1	+0.3%	+$98	0.02%	79
2025 Q3	$31K	Hold	318	–	–	0.02%	78
2025 Q2	$34.2K	Buy	+318	New	+$32.2K	0.01%	60
2016 Q1	–	Sell	-2,135	Closed	-$39K	–	168
2015 Q4	$39K	Buy	+2,135	New	+$38.3K	0.01%	153

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Howard Hughes Medical Institute's BSX Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 319 shares — an estimated $30.4K sold.

Howard Hughes Medical Institute first reported a position in BSX in Q4 2015 and held it in 4 quarters. The position peaked at $39K in Q4 2015. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 319 Boston Scientific shares in Q1 2026, an estimated $30.4K.
Howard Hughes Medical Institute first reported a position in Boston Scientific in Q4 2015 and held it in 4 quarters.
Howard Hughes Medical Institute's Boston Scientific position peaked at $39K in Q4 2015.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.